Functional β3-adrenoceptor in the human heart

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 556-562

  Gauthier, Chantal ^a,b   Tavernier, Geneviève ^c   Charpentier, Flavien ^a   Langin, Dominique ^c   Le Marec, Hervé ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

human action potential; human myocardium; negative inotropy; adrenoceptors; 3 adrenoceptor transcripts

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRANOLOL; CATECHOLAMINE; ISOPRENALINE; MESSENGER RNA; NADOLOL; [[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER; BETA ADRENERGIC RECEPTOR; BORDETELLA VIRULENCE FACTOR; PRIMER DNA;

ACTION POTENTIAL; ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPOLARIZATION; BIOPSY; BIOSYNTHESIS; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE; HEART TRANSPLANTATION; HEART VENTRICLE; IN VITRO STUDY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

ACTION POTENTIALS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; BASE SEQUENCE; BIOPSY; DNA PRIMERS; FEMALE; HEART; HEART TRANSPLANTATION; HEART VENTRICLES; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIAL CONTRACTION; MYOCARDIUM; NADOLOL; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-3; STRUCTURE-ACTIVITY RELATIONSHIP; VIRULENCE FACTORS, BORDETELLA;

EID: 0029665961     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118823     Document Type: Article

References (41)

1. Bylund, D.V., D.C. Einkenberg, J.P. Hieble, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman, P.B. Molinoff, R.R. Ruffolo, and U. Trendelenburg. 1994. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46:121-136.
2. 3-adrenoceptor receptor gene. Mol. Pharmacol. 44:264-270.
3. Strosberg, A.D. 1993. Structure, function, and regulation of adrenoceptor receptors. Protein Sci. 2:1198-1209.
4. Arch, J.R.S., A.T. Ainsworth, M.A. Cawthorne, V. Piercy, M.V. Sennit, V.E. Thody, C. Wilson, and S. Wilson. 1984. Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature (Lond.). 309:163-165.
5. Zaagsma, J., and S.R. Nahorski. 1990. Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical beta 3-adrenoceptor? Trends Pharmacol. Sci. 11:3-7.
6. Langin, D., M.P. Portillo, J.S. Saulnier-Blache, and M. Lafontan. 1991. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol. 199:291-301.
7. 3-adrenoceptor in man. Br. J. Pharmacol. 110:929-936.
8. 3-adroneceptor receptors. Fundam. & Clin. Pharmacol. 9:211-218.
9. 3-adrenoceptor receptors. J. Clin. Invest. 95:923.
10. Bond, R.A., and D.E. Clarke. 1988. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the α- and β-subtypes. Br. J. Pharmacol. 95:723-734.
11. Manara, L., and A. Bianchetti. 1990. The phenylethanoaminotetralines: new selective agonists for atypical β-adrenoceptors. Trends Pharmacol. Sci. 11: 229-230.
12. 3-adrenoceptor in the relaxation response in guinea pig taenia caecum. Jpn. J. Pharmacol. 66:213-220.
13. 3-adrenoceptors and airways. Fundam. & Clin. Pharmacol. 9:114-118.
14. Berlan, M., J. Galitzky, A. Bousquet-Melou, M. Lafontan, and J.L. Montastruc. 1994. beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog. J. Pharmacol. Exp. Ther. 268:1444-1451.
15. Shen, Y.T., H. Zhang, and F. Vatner. 1994. Peripheral vascular effects of beta-3 adrenoceptor receptor stimulation in conscious dogs. J. Pharmacol. Exp. Ther. 268:466-473.
16. Kaumann, A.J. 1989. Is there a third heart β-adrenoceptor? Trends Pharmacol. Sci. 10:316-320.
17. Kaumann, A.J., and B.M. Lobnig. 1986. Mode of action of (-)-pindolol on feline and human myocardium. Br. J. Pharmacol. 89:207-218.
18. Tavernier, G., J. Galitzky, A. Bousquet-Melou, J.L. Montastruc, and M. Berlan. 1992. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenoceptor agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms. J. Pharmacol. Exp. Ther. 263:1083-1090.
19. 3-adrenoceptor agonist in isolated, blood-perfused dog atria. Eur. J. Pharmacol. 231:315-321.
20. 3-adrenoceptors in man. Q. J. Med. 86:255-261.
21. 3-adrenoceptor agonist BRL 35135 in man. Br. J. Clin. Pharmacol. 37:363-369.
22. Brodde, O.E. 1993. β-adrenoceptors in cardiac disease. Pharmacol. & Ther. 60:405-430.
23. Gauthier, C., K. Laurent, F. Charpentier, E. Drouin, J.C. Chevallier, and H. Le Marec. 1994. Endomyocardial biopsies: a new approach for studying the electrical and mechanical properties of human ventricular myocardium. J. Mol. Cell. Cardiol. 26:1267-1271.
24. Lelias, J.M., M. Kaghad, M. Rodriguez, P. Chalon, J. Bonnin, I. Dupre, B. Delpech, M. Bensaid, G. LeFur, P. Ferrara, and D. Caput. Molecular cloning of a human beta 3-adrenoceptor receptor cDNA. FEBS Lett. 324:127-130.
25. Lee, R.J., D.E. Evans, S.H. Baky, and R.J. Laffan. 1975. Pharmacology of nadolol (SQ 11725), a beta-adrenoceptor antagonist lacking direct myocardial depression. Eur. J. Pharmacol. 33:371-382.
26. Dolan, J.A., H.A. Muenkel, M.G. Burns, S.M. Pellegrino, C.M. Fraser, F. Pietri, A.D. Strosberg, E.E. Largis, M.D. Dutia, J.D. Bloom et al. 1994. Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther. 269:1000-1006.
27. Galitzky, J., M. Reverte, C. Carpene, M. Lafontan, and M. Berlan. 1993. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines. J. Pharmacol. Exp. Ther. 266:358-366.
28. Langin, D., H. Laurell, L. Stenson Holst, P. Belfrage, and C. Holm. 1993. Gene organization and primary structure of human hormone-sensitive lipase: possible significance of a sequence of homology with a lipase of Moraxella TA144, an antartic bacterium. Proc. Natl. Acad. Sci. USA. 90:4897-4901.
29. Jones, C.R., P. Molenaar, and R.J. Summers. 1989. New views of human cardiac β-adrenoceptors. J. Mol. Cell. Cardiol. 21:519-535.
30. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur. Heart J. 10(Suppl. B):29-37.
31. Bristow, M.R., R.E. Hershberger, J.D. Port, E.M. Gilbert, A. Sandoval, R. Rasmussen, A.E. Cates, and A.M. Felman. 1990. β-adrenoceptor pathways in nonfailing and failing human ventricular myocardium. Circulation. 82(Suppl. I):12-25.
32. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 43: 203-242.
33. 2-adrenoceptors in single myocytes from human ventricle. Circulation. 88:854-863.
34. 3-adrenoceptor receptor. Science (Wash. DC). 245:1118-1121.
35. Sugasawa, T., M. Matsuzaki, S. Morooka, N. Foignant, N. Blin, and A.D. Strosberg. 1992. In vitro study of a novel atypical beta-adrenoceptor agonist, SM-1044. Eur. J. Pharmacol. 216:207-215.
36. 3-adrenoceptor receptor mRNA in man. J. Clin. Invest. 91:344-349.
37. 3-adrenoceptor mRNA in human tissues. Eur. J. Pharmacol. 289:223-228.
38. Piepho, R.W. 1991. Heterogeneity of calcium channel blockers. Hosp. Pharm. 26:856-864.
39. i in rat adipocytes. Cell Signalling. 6:457-465.
40. 3-adrenoceptor activation of adenylyl cyclase in mouse white adipocytes: modulation by GTP and effect of obesity. J. Cell. Biochem. 58:464-473.
41. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol. Pharmacol. 47:322-329.